BRIEF-Acelrx Pharmaceuticals updates on notification from U.S. FDA By: Reuters: Company News June 07, 2017 at 06:53 AM EDT * U.S. FDA notified co that it no longer plans to hold an advisory committee meeting in connection with its review of NDA for Dsuvia Read More >> Related Stocks: Acelrx Pharmaceutica